Pro Share Advisors LLC Blueprint Medicines Corp Transaction History
Pro Share Advisors LLC
- $36.7 Billion
- Q1 2024
A detailed history of Pro Share Advisors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,218 shares of BPMC stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,218
Previous 13,950
9.09%
Holding current value
$1.78 Million
Previous $1.29 Million
12.21%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding BPMC
# of Institutions
316Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$753 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$737 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$730 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$488 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$292 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...